General Information
Revision date
2017-05-11
Product name
doxorubicin, hydrochloride
Substance name
doxorubicin, hydrochloride
Product Synonyms
(8S-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro- 6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride / 10-
CAS No.
25316-40-9
Emergency telephone
1-800-424-9300 (USA/Canada), +1-703-527-3887 (Intl
Icons in SDS
Company Information
company name
Geno Technology, Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
technical@GBiosciences.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H351
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Mixtures/Substances SDS EU 2015 According to Regulation (EU) 2015/830 (REACH Annex II) Acute toxicity (oral), Category 4 H302 Carcinogenicity, Category 2 H351
Hazard statements
see section 16 : H302 - Harmful if swallowed. H351 - Suspected of causing cancer.
Adverse physicochemical, human health and environmental effects
Suspected of causing cancer. Harmful if swallowed.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P308+P313 - IF exposed or concerned: Get medical advice/attention. P330 - Rinse mouth. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
No additional information available
